Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | VIMTALABS Vimta Labs Limited Pharma · Small | VENUSREM Venus Remedies Limited Pharma · Small | LINCOLN Lincoln Pharmaceuticals Limited Pharma · Small | SMSPHARMA SMS Pharmaceuticals Limited Pharma · Small |
|---|---|---|---|---|
| Final Score | 46 | 60 | 45 | 41 |
| Verdict | FAIR VALUE | UNDERVALUED | WATCHLIST | WATCHLIST |
| Style | Financial Turnaround | Growth at Value | Financial Turnaround | WATCHLIST |
| Piotroski | 8/9 | 7/9 | 8/9 | 8/9 |
| Valuation | 3/30 | 13/30 | 15/30 | 5/30 |
| Growth | 17/25 | 18/25 | 7/25 | 11/25 |
| Quality | 8/20 | 13/20 | 2/20 | 7/20 |
| Balance Sheet | 9/15 | 8/15 | 12/15 | 9/15 |
| Cash Flow | 4/10 | 4/10 | 4/10 | 4/10 |
| Price | ₹527.85 | ₹1,610.7 | ₹637.8 | ₹377.45 |
| P/E | 38.70 | 22.00 | 14.10 | 33.90 |
| P/B | 6.83 | 3.41 | 1.64 | 4.40 |
| ROE | 13.50% | 16.80% | 12.30% | 14.30% |
| ROCE | 17.60% | 21.70% | 16.30% | 13.30% |
| Debt / Equity | 0.04 | 0.02 | 0.01 | 0.46 |
| FCF Yield | — | — | 0.64% | — |
| Dividend Y | 0.38% | — | 0.29% | 0.11% |
| Altman Z | 8.95 | 8.81 | 8.23 | 5.66 |
| Promoter % | 35.85% | 41.76% | 49.78% | 68.07% |
| Mkt Cap (₹Cr) | 2354.00 | 2266.00 | 1241.00 | 3454.00 |
| Graham # | ₹155.05 | ₹927.33 | ₹610.9 | ₹143.38 |
| Fair PE | 42.0 | 42.0 | 19.1 | 42.3 |
| MoS % | +9.2% | +50.1% | +23.9% | +18.1% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startVIMTALABS76
VENUSREM508
LINCOLN96
SMSPHARMA128